Literature DB >> 8771027

Use of nitroxides for assessing perfusion, oxygenation, and viability of tissues: in vivo EPR and MRI studies.

B Gallez1, G Bacic, F Goda, J Jiang, J A O'Hara, J F Dunn, H M Swartz.   

Abstract

Relative perfusion, pO2, and bioreduction were measured simultaneously in vivo in tissues in mice by following changes in the intensity and shape of the EPR spectra of nitroxides injected directly into the tissues, using low frequency (1.1 GHz) localized EPR spectroscopy. Using normal and blood flow restricted gastrocnemius muscles it was shown that the decrease of the EPR signals of the nitroxides in tissues was due principally to perfusion, which redistributed the nitroxides. Changes in pO2 were reflected by changes of the linewidth; only a perdeuterated nitroxide with a narrow line was an adequate indicator for this parameter. This technique was applied experimental murine tumors (MTG-B and RIF-1) to determine the perfusion and pO2 in these relatively hypoxic model tumor systems. Using the paramagnetic properties of the nitroxides to enhance T1-weighted MR images, heterogeneity in perfusion in individual tumors was demonstrated

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8771027     DOI: 10.1002/mrm.1910350113

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  27 in total

1.  Simultaneous molecular imaging of redox reactions monitored by Overhauser-enhanced MRI with 14N- and 15N-labeled nitroxyl radicals.

Authors:  Hideo Utsumi; Ken-ichi Yamada; Kazuhiro Ichikawa; Kiyoshi Sakai; Yuichi Kinoshita; Shingo Matsumoto; Mika Nagai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  Carbon-centered radicals as oxygen sensors for in vivo electron paramagnetic resonance: screening for an optimal probe among commercially available charcoals.

Authors:  B F Jordan; C Baudelet; B Gallez
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

3.  Development of biocompatible implants of fusinite for in vivo EPR oximetry.

Authors:  B Gallez; R Debuyst; K J Liu; R Demeure; F Dejehet; H M Swartz
Journal:  MAGMA       Date:  1996-03       Impact factor: 2.310

Review 4.  Theory, instrumentation, and applications of electron paramagnetic resonance oximetry.

Authors:  Rizwan Ahmad; Periannan Kuppusamy
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 5.  Oxidative stress imaging in live animals with techniques based on electron paramagnetic resonance.

Authors:  Martyna Elas; Kazuhiro Ichikawa; Howard J Halpern
Journal:  Radiat Res       Date:  2012-02-21       Impact factor: 2.841

6.  In vivo measurement of tumor redox environment using EPR spectroscopy.

Authors:  Govindasamy Ilangovan; Haiquan Li; Jay L Zweier; Periannan Kuppusamy
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 7.  Measurements in vivo of parameters pertinent to ROS/RNS using EPR spectroscopy.

Authors:  Nadeem Khan; Harold Swartz
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 8.  Clinical EPR: unique opportunities and some challenges.

Authors:  Harold M Swartz; Benjamin B Williams; Bassem I Zaki; Alan C Hartford; Lesley A Jarvis; Eunice Y Chen; Richard J Comi; Marc S Ernstoff; Huagang Hou; Nadeem Khan; Steven G Swarts; Ann B Flood; Periannan Kuppusamy
Journal:  Acad Radiol       Date:  2014-02       Impact factor: 3.173

9.  In vivo EPR oximetry using an isotopically-substituted nitroxide: Potential for quantitative measurement of tissue oxygen.

Authors:  John Weaver; Scott R Burks; Ke Jian Liu; Joseph P Y Kao; Gerald M Rosen
Journal:  J Magn Reson       Date:  2016-08-16       Impact factor: 2.229

10.  Tumor Xenograft Response to Redox-Active Therapies Assessed by Magnetic Resonance Imaging Using a Thiol-Bearing DOTA Complex of Gadolinium.

Authors:  Gerald P Guntle; Bhumasamudram Jagadish; Eugene A Mash; Garth Powis; Robert T Dorr; Natarajan Raghunand
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.